SoluBest was founded in 2001 to develop an easy-to-integrate technological platform for solving one of the most pressing issues facing the pharma industry: the problem of drug insolubility.
Solubility or the lack thereof, is the single most significant issue in the formulation of drugs: over 40% of the drugs on the market, and up to 60% of drugs currently in development, are insoluble, presenting drug developers with severe problems in effectively delivering these drugs to patients.
SoluBest’s proprietary Solumer™ process addresses this issue by creating proprietary smart drug-polymer assemblages in which active drug molecules are uniquely interwoven within FDA-approved polymers. Once in the body, these formulations disintegrate into stable nanoparticles, significantly increasing drug solubility and oral absorption, thus improving the performance of insoluble active substances.